Key result
TAVI-associated prosthetic valve endocarditis carries extremely high surgical risk during explantation.
Why the study?
Prosthetic valve endocarditis following transcatheter aortic valve implantation is rarely reported but poses a serious concern due to high surgical risk for these patients.
Prosthetic valve endocarditis following TAVI is a rare but serious complication given the high surgical risk of these patients.
High surgical risk in post-TAVI endocarditis warrants caution in explant decisions; leaves optimal management strategies open for prospective study.
There are only a few cases of prosthetic valve endocarditis (PVE) following transcatheter aortic valve implantation (TAVI) reported in the literature. Though not very frequent, this is a serious concern because patients are high risk for surgical aortic valve replacement (SAVR) by definition, and explanting the endocarditic prosthetic valve followed by SAVR increases risk even higher.
No takes yet. Share an insight, caveat, or question.
Neragi-Miandoab et al. (2015) studied this question. Prosthetic valve endocarditis following transcatheter aortic valve implantation is a rare but severe complication associated with extremely high surgical risk for valve explantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: